| 000 | 01336 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250512205214.0 | ||
| 264 | 0 | _c19830214 | |
| 008 | 198302s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.22.4.617 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIshitsuka, H | |
| 245 | 0 | 0 |
_aDirect and specific inactivation of rhinovirus by chalcone Ro 09-0410. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cOct 1982 |
||
| 300 |
_a617-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aChalcone _xanalogs & derivatives |
| 650 | 0 | 4 | _aChalcones |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPicornaviridae Infections _xdrug therapy |
| 650 | 0 | 4 |
_aPropiophenones _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Viral _xbiosynthesis |
| 650 | 0 | 4 |
_aRhinovirus _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aVirus Replication _xdrug effects |
| 700 | 1 | _aNinomiya, Y T | |
| 700 | 1 | _aOhsawa, C | |
| 700 | 1 | _aFujiu, M | |
| 700 | 1 | _aSuhara, Y | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 22 _gno. 4 _gp. 617-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.22.4.617 _zAvailable from publisher's website |
| 999 |
_c6295186 _d6295186 |
||